SCHEMBL30830759

SCHEMBL30830759

CC(C)(C)OC(=O)N1CC2(C1)CN(c1cccc(-c3ccc(OCc4ccccc4)nc3OCc3ccccc3)c1)C2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 6/20 0.40
ALDH1A1 P00352 5/20 0.40
HPGD P15428 4/20 0.40
MAPK1 P28482 2/20 0.40
HIF1A Q16665 1/20 0.40
USP30 Q70CQ3 1/20 0.40
EGLN2 Q96KS0 1/20 0.39
USP2 O75604 4/20 0.39
CYP1A2 P05177 4/20 0.39
GPR119 Q8TDV5 4/20 0.39
TSHR P16473 2/20 0.39
CYP3A4 P08684 3/20 0.38
CYP2D6 P10635 3/20 0.38
SCD5 Q86SK9 1/20 0.38
CCNT1 O60563 1/20 0.38
CCNA2 P20248 1/20 0.38
CDK2 P24941 1/20 0.38
CDK9 P50750 1/20 0.38
CCNA1 P78396 1/20 0.38
TLR9 Q9NR96 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30965537 0.93 SCD5 (0.44) HSD17B10ALDH1A1HPGDMAPK1HIF1A
SCHEMBL30831067 0.93 HSD17B10 (0.51) HSD17B10ALDH1A1HPGDMAPK1HIF1A
SCHEMBL30112318 0.91 ALK (0.42) HSD17B10ALDH1A1HPGDMAPK1EGLN2
SCHEMBL25034770 0.89 GPR119 (0.50) ALDH1A1GPR119CCNT1CCNA2CDK2
SCHEMBL30830960 0.89 GPR119 (0.50) ALDH1A1GPR119CCNT1CCNA2CDK2
SCHEMBL30768744 0.89 USP2 (0.50) HSD17B10ALDH1A1HPGDMAPK1HIF1A
SCHEMBL31585285 0.86 PARP1 (0.41) EGLN2GPR119CCNT1CCNA2CDK2
SCHEMBL30830629 0.83 CYP3A4 (0.48) HSD17B10ALDH1A1HPGDMAPK1HIF1A
SCHEMBL26641312 0.83 GPR119 (0.44) HSD17B10ALDH1A1HPGDMAPK1USP2
SCHEMBL31342432 0.82 YAP1 (0.44) GPR119PRMT5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4581025-A1 PYRIDAZINON DERIVATIVES AS KAT2 DEGRADERS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS Auron Therapeutics, Inc. (US) 2025-07-09 EP disclosed
WO-2024050078-A1 PYRIDAZINON DERIVATIVES AS KAT2 DEGRADERS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS AURON THERAPEUTICS, INC. (US) 2024-03-07 WO disclosed